Cidara Therapeutics, Inc. (CDTX)
220.08
+0.48
(+0.22%)
USD |
NASDAQ |
Dec 11, 16:00
220.36
+0.28
(+0.12%)
After-Hours: 17:24
Cidara Therapeutics Cash from Investing (Quarterly): -176.47M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -283.00M |
| Bristol Myers Squibb Co. | -1.702B |
| Johnson & Johnson | -542.00M |
| Mersana Therapeutics, Inc. | 0.372M |
| Pfizer Inc. | -2.43B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.62M |
| Cash from Financing (Quarterly) | 0.16M |
| Free Cash Flow | -132.94M |
| Free Cash Flow Per Share (Quarterly) | -1.511 |
| Free Cash Flow to Equity (Quarterly) | -40.27M |
| Free Cash Flow to Firm (Quarterly) | -40.62M |
| Free Cash Flow Yield | -3.64% |